Correlation between structure of dihydropyridine calcium antagonists and their retention behavior and enantioseparation on the β‐cyclodextrin stationary phase in HPLC
暂无分享,去创建一个
[1] K. Lipkowitz. Theoretical studies of type II–V chiral stationary phases , 1995 .
[2] D. Manallack,et al. Chiral recognition of structurally related aminoalkylphosphonic acid derivatives on an acetylated beta-cyclodextrin bonded phase , 1994 .
[3] D. Durham,et al. Molecular modelling of the inclusion complexes between beta-cyclodextrin and (R)/(S)-methylphenobarbitone and its application to HPLC. , 1994, Chirality.
[4] G. Schomburg,et al. Molecular modelling experiments on chiral recognition in GC with specially derivatized cyclodextrins as selectors , 1993 .
[5] G. Pappalardo,et al. Molecular Modeling of β‐Cyclodextrin Complexes with Nootropic Drugs , 1992 .
[6] R. Meier,et al. The separation of enantiomers on modified cyclodextrin columns: Measurements and molecular modeling , 1992 .
[7] K. Lipkowitz,et al. Enantioselective binding of tryptophan by .alpha.-cyclodextrin , 1992 .
[8] Alfred S. Kostense,et al. Modeling and conformation analysis of β-cyclodextrin complexes , 1991, J. Comput. Aided Mol. Des..
[9] D. Breimer,et al. Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects. , 1991, British journal of clinical pharmacology.
[10] D. Armstrong,et al. Structural factors affecting chiral recognition and separation on β-cyclodextrin bonded phases , 1988 .
[11] J. Maguire. Some structural requirements for resolution of hydantoin enantiomers with a beta-cyclodextrin liquid chromatography column. , 1987, Journal of chromatography.
[12] D. Armstrong,et al. Separation of drug stereoisomers by the formation of beta-cyclodextrin inclusion complexes. , 1986, Science.
[13] U. Ruegg,et al. Stereoselectivity at the Calcium Channel: Different Profiles of Hemodynamic Activity of the Enantiomers of the Dihydropyridine Derivative PN 200-110 , 1986, Journal of cardiovascular pharmacology.